-
公开(公告)号:DK144656B
公开(公告)日:1982-05-03
申请号:DK183374
申请日:1974-04-02
Applicant: ABBOTT LAB
Inventor: WINN M
IPC: A61K31/435 , A61P25/04 , A61P25/20 , C07C37/055 , C07C43/205 , C07D491/04 , C07D491/052
-
公开(公告)号:SE413244B
公开(公告)日:1980-05-12
申请号:SE7404386
申请日:1974-04-01
Applicant: ABBOTT LAB
Inventor: WINN M , LYNN K R , MARTIN Y C
IPC: C07C37/055 , C07D213/30 , C07D213/50 , C07D311/80 , C07D311/94 , C07D407/06
Abstract: 1459564 Derivatives of dibenzopyran and cyclopentabenzopyran ABBOTT LABORATORIES 1 April 1974 [2 April 1973 13 Feb 1974] 14404/74 Heading C2C The invention comprises compounds of formulµ and the pharmaceutically acceptable salts of (I), (II) and (III), wherein n is 1 or 2; R and R 1 are each H or C 1-6 alkyl [but in the pyrone compound (XIII), H or Me]; R 2 is C 1-6 alkyl; Y is C 1-10 alkylene; R 4 , R 5 , R 6 are each H, halogen, CF 3 or C 1-6 alkyl; and Z is C or N. In examples, (XIII) are prepared by reacting an ethyl cyclopentanone (or cyclohexanone)-2-carboxylate with an appropriate 5-aralkylresorcinol (A), and converted into (I) and (II) by reaction with R 2 MgBr, followed optionally by hydrogenation to give (III). Starting materials prepared are the dimethyl ethers of (A), the benzene compounds where Q is CH : CHCO 2 H, CH 2 CH 2 CO 2 H, (CH 2 ) 3 OH, (CH 2 ) 3 Br, (CH 2 ) 5 OH and (CH 2 ) 3 Br, and the compounds 3,5-(MeO) 2 C 6 H 3 CR 0 R 0 - alkylene-Ar where CR 0 R 0 is CO or one R‹ is Me and the other is OH, and Ar is R 4 R 5 R 6 C 5 HZ-. Therapeutic compositions for oral, parenteral or rectal administration comprise the above compounds (Ia), which are analgesics, mild tranquillizers and antidiarrhoeals.
-
公开(公告)号:ZA7001064B
公开(公告)日:1971-09-29
申请号:ZA7001064
申请日:1970-02-17
Applicant: ABBOTT LAB
Inventor: CROVETTI A , BLANK A , KENNEY D , WINN M , GERMANN R , HASBROUCK R
IPC: A01N41/10 , C07C315/04 , C07C317/04 , C07C317/10 , C07C317/12 , C07C317/14 , C07C317/18 , C07C317/22 , C07C317/40 , C08K5/41 , C09D5/08 , C09D5/14 , A01N
CPC classification number: C08K5/41 , C07C315/04 , C07C317/04 , C07C317/10 , C07C317/12 , C07C317/14 , C07C317/18 , C07C317/22 , C07C317/40 , C07C2601/14
-
公开(公告)号:SE422685B
公开(公告)日:1982-03-22
申请号:SE7611379
申请日:1976-10-13
Applicant: ABBOTT LAB
Inventor: WINN M , KYNCL J , DUNNIGAN D A , JONES P H
IPC: C07D405/12 , A61K31/505 , A61P9/12 , A61P25/04 , C07D309/08 , C07D405/14
Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyqui nazoline, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
-
公开(公告)号:SE410969B
公开(公告)日:1979-11-19
申请号:SE7404387
申请日:1974-04-01
Applicant: ABBOTT LAB
Inventor: WINN M
IPC: A61K31/435 , A61P25/04 , A61P25/20 , C07C37/055 , C07C43/205 , C07D491/04 , C07D491/052
-
公开(公告)号:AU502420B2
公开(公告)日:1979-07-26
申请号:AU1759176
申请日:1976-09-09
Applicant: ABBOTT LAB
Inventor: WINN M , KYNCL J , DUNNIGAN D A , JONES P H
IPC: C07D405/14 , A61K31/495 , A61K31/505 , A61K31/55 , A61P9/12 , C07D239/84 , C07D239/95 , C07D243/00 , C07D243/08 , C07D307/14 , C07D405/06 , C07D407/14
Abstract: Described are the compounds 2[4(tetrahydro-2-furoyl)-hexahydro-1,4-diazepinyl-1]-4-amino-6,7-dimet hoxy quinazoline and pharmaceutically acceptable acid addition salts thereof. The compounds are useful as antihypertensive agents.
-
公开(公告)号:ZA741535B
公开(公告)日:1975-02-26
申请号:ZA741535
申请日:1974-03-08
Applicant: ABBOTT LAB
IPC: C07D7/02
-
公开(公告)号:ZA7401535B
公开(公告)日:1975-02-26
申请号:ZA7401535
申请日:1974-03-08
Applicant: ABBOTT LAB
IPC: C07D7/02
-
公开(公告)号:SE8008533L
公开(公告)日:1980-12-04
申请号:SE8008533
申请日:1980-12-04
Applicant: ABBOTT LAB
Inventor: WINN M , KYNCL J , DUNNINGAN D A , JONES P H
IPC: C07D405/12 , A61K31/505 , A61P9/12 , A61P25/04 , C07D309/08 , C07D405/14
Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyqui nazoline, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
-
公开(公告)号:SE7906433L
公开(公告)日:1980-11-08
申请号:SE7906433
申请日:1979-07-27
Applicant: ABBOTT LAB
Inventor: WINN M , NORDEEN C W
IPC: C07D231/38 , C07D231/40 , C07D403/12
-
-
-
-
-
-
-
-
-